U.S. flag

An official website of the United States government

NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter) AND Arrhythmogenic right ventricular cardiomyopathy

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 13, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000211843.14

Allele description [Variation Report for NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)]

NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)

Gene:
PKP2:plakophilin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p11.21
Genomic location:
Preferred name:
NM_001005242.3(PKP2):c.235C>T (p.Arg79Ter)
Other names:
p.R79*:CGA>TGA
HGVS:
  • NC_000012.12:g.32879021G>A
  • NG_009000.1:g.22826C>T
  • NM_001005242.3:c.235C>TMANE SELECT
  • NM_004572.4:c.235C>T
  • NP_001005242.2:p.Arg79Ter
  • NP_004563.2:p.Arg79Ter
  • NP_004563.2:p.Arg79Ter
  • LRG_398t1:c.235C>T
  • LRG_398:g.22826C>T
  • LRG_398p1:p.Arg79Ter
  • NC_000012.11:g.33031955G>A
  • NM_004572.3:c.235C>T
  • NM_004572.4:c.235C>T
  • c.235C>T
  • p.Arg79X
Protein change:
R79*; ARG79TER
Links:
OMIM: 602861.0001; dbSNP: rs121434420
NCBI 1000 Genomes Browser:
rs121434420
Molecular consequence:
  • NM_001005242.3:c.235C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_004572.4:c.235C>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
10

Condition(s)

Name:
Arrhythmogenic right ventricular cardiomyopathy (ARVD)
Synonyms:
Cardiomyopathy, ARVC; Arrhythmogenic right ventricular dysplasia
Identifiers:
MONDO: MONDO:0016587; MeSH: D019571; MedGen: C0349788

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000061874Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Pathogenic
(Feb 13, 2019)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown3210not providednot providednot providedclinical testing

Citations

PubMed

Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia.

van der Zwaag PA, Cox MG, van der Werf C, Wiesfeld AC, Jongbloed JD, Dooijes D, Bikker H, Jongbloed R, Suurmeijer AJ, van den Berg MP, Hofstra RM, Hauer RN, Wilde AA, van Tintelen JP.

Neth Heart J. 2010 Dec;18(12):583-91.

PubMed [citation]
PMID:
21301620
PMCID:
PMC3018603

Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders?

Christensen AH, Benn M, Tybjaerg-Hansen A, Haunso S, Svendsen JH.

Cardiology. 2010;115(2):148-54. doi: 10.1159/000263456. Epub 2009 Dec 3.

PubMed [citation]
PMID:
19955750
See all PubMed Citations (11)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000061874.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided32not providednot providedclinical testing PubMed (11)

Description

The p.Arg79X variant in PKP2 has been previously identified in >15 individuals with ARVC and segregated with disease in >15 affected individuals from >5 families (Gerull 2004, Dalal 2006, van Tintelen 2006, den Haan 2009, Christensen 2010, van der Zwaag 2010, Larsen 2012, Noorman 2013, Rasmussen 2014, LMM data). This variant has also been identified in 1/111652 European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This nonsense variant leads to a premature termination codon at position 79, which is predicted to lead to a truncated or absent protein. In vitro functional studies support that this variant results in reduced PKP2 expression (Joshi-Mukherjee 2008). Heterozygous loss of PKP2 function is an established disease mechanism in individuals with ARVC. In summary, this variant meets criteria to be classified as pathogenic for ARVC in an autosomal dominant manner. ACMG/AMP Criteria applied: PVS1, PS4, PP1_Strong, PM2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided32not provided10not provided

Last Updated: Oct 20, 2024